[1] |
.
[J]. Clinical Focus, 2022, 37(7): 658-662.
|
[2] |
.
[J]. Clinical Focus, 2022, 37(5): 477-480.
|
[3] |
.
[J]. CLINICAL FOCUS, 2013, 28(11): 1312-1315.
|
[4] |
.
[J]. Clinical Focus, 2012, 27(22): 1970-1971.
|
[5] |
.
[J]. CLINICAL FOCUS, 2011, 26(20): 1830-1834.
|
[6] |
.
[J]. CLINICAL FOCUS, 2010, 25(23): 2071-2073.
|
[7] |
LI Xue-feng;QIN Gui-jun;LI Zhi-zhen;RAO Xiao-juan;MA Xiao-jun.
mRNA expression of FOXOI and GLUT4 in omental adipose tissue of obese individuals and their relation with insulin resistance
[J]. CLINICAL FOCUS, 2009, 24(16): 1388-1391.
|
[8] |
.
[J]. CLINICAL FOCUS, 2009, 24(10): 913-915.
|
[9] |
.
[J]. CLINICAL FOCUS, 2009, 24(8): 699-700.
|
[10] |
.
[J]. CLINICAL FOCUS, 2009, 24(5): 451-452.
|
[11] |
.
[J]. CLINICAL FOCUS, 2008, 23(3): 206-207.
|
[12] |
.
[J]. CLINICAL FOCUS, 2008, 23(3): 216-217.
|
[13] |
.
Concentration of interleukin-6 in plasma of obesity with type 2 diabetes mellitus patients and insulin resistance
[J]. CLINICAL FOCUS, 2004, 19(12): 672-674.
|